Becker's Healthcare July 24, 2024
Andrew Cass

The R1 RCM special committee has set a July 31 deadline for interested parties to submit fully-financed bids in connection with its review process.

R1 formed the special committee of independent directors in February in the wake of two major shareholders mulling an offer to take the company private.

“No assurances can be given regarding the outcome or timing of the special committee’s review process,” R1 said in a July 24 news release. “The special committee continues to evaluate all alternatives for R1, including continued execution of its strategic plan as a public company. R1 does not intend to make any further public comment regarding the review unless and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: RCM (Revenue Cycle Mgmt), Technology
Related Articles:
Aspirion lands 7th acquisition in 6 years
Revenue Cycle Risk Takers
Revenue Cycle AI Is Costly and Cumbersome. Here's Why Leaders Are Still Buying In.
Medical Tourism and Global Private Healthcare Drive Revenue Cycle Innovation: Black Book Report
4 Cornerstones for Successful AI Implementation in Hospital Revenue Cycle Management in 2025

Share This Article